Dr. Omerovic claimed that the key message is that “there should be more radial access performed in the United States.” The 90% radial access in this study is reflective of current practice in Sweden and most other European countries, according to Dr. Omerovic. In contrast, the U.S. rate is closer to 60% by some estimates.
“I would always be concerned that if you are performing radial access 90% of the time, you are going to lose your femoral skills,” Dr. Grines said. Like other U.S. interventionalists who commented during an animated discussion, she insisted that a prospective randomized trial, not a subgroup analysis, is needed before declaring radial access preferred.
Dr. Omerovic reports financial relationships with AstraZeneca, Bayer, and Boston Scientific.
SOURCE: Omerovic E. CRT 2018.